The Official News & Technical Journal Of The International Society For Pharmacoeconomics And Outcomes Research

ISPOR Fifth Annual European Congress Scientific Awards Winners

by Nadia Naaman, Director, Marketing & Member Services

During the ISPOR Fifth Annual European Congress, 3-5 November 2002, De Doelen Congress Center, Rotterdam, The Netherlands, the scientific merit exhibited in contributed poster and podium presentations was recognized with awards given by authors' groups: general, new investigators and students. This year, the ISPOR Awards Committee evaluated approximately  48 podium presentations andover 326 poster presentations.

ISPOR Best Contributed Podium Presentation Award

BEST GENERAL PODIUM PRESENTATIONS

UT1 36 INTO 1 DOESN'T GO
Kind P, University of York, York, England

CV3 MULTI-COUNTRY COMPARISON OF HYPERTENSION COSTS FROM HOSPITALIZATIONS AND AMBULATORY CARE
Mullins CD1, Sikirica M1, Seneviratne V1, Ahn J1, Akhras KS2, 1University of Maryland, Baltimore, MD, USA; 2Pharmacia Corporation, Skokie, IL, USA

CC3 MEASURING POPULATION HEALTH FOR 191 COUNTRIES: WHO METHODS AND RESULTS
Mathers CD, Salomon J, Murray CJ, Tandon A, Sadana R, Ustun B, World Health Organization, Switzerland, Switzerland

BEST NEW INVESTIGATOR PODIUM PRESENTATIONS

WP3 WILLINGNESS TO PAY FOR A PHARMACIST INTERVENTION PROGRAM AMONG NON-COMPLIANT DYSLIPIDEMIA PATIENTS
Ali F, Laurin MY, Lariviere C, Tremblay D, Cloutier D, Pfizer Canada Inc, Kirkland,
QC, Canada

MD4 CHANGES IN COST-EFFECTIVENESS OVER TIME: THE CASE OF EPOETIN ALFA FOR RENAL REPLACEMENT THERAPY PATIENTS IN THE UK
Remak E1, Hutton J1, Zagari M2, 1MEDTAP International, London, UK; 2Ortho-Biotech, UK/Ireland, High Wycombe, United Kingdom

MD5 SHOULD THE EUROQOL DESCRIPTIVE SYSTEM BE EXTENDED FROM THREE TO FIVE LEVELS? A METHODOLOGICAL STRATEGY WITH AN EMPIRICAL PILOT
Janssen MF, Bonsel GJ, Academic Medical Centre, Amsterdam, Netherlands

BEST STUDENT PODIUM PRESENTATIONS

WP1 WILLINGNESS TO PAY FOR PHARMACIST-PROVIDED MENOPAUSE
AND HORMONE REPLACEMENT THERAPY CONSULTATIONS

Branvold AE, Barner J, Vincze G, University of Texas at Austin, Austin, TX, USA

WP2 ESTIMATING WILLINGNESS TO PAY FOR DRUGS TO TREAT ADHD. A CONTINGENT VALUATION STUDY IN STUDENTS
De Ridder A, De Graeve D, University of Antwerp, Antwerpen, Belgium

UT2 THE TRANSFORMATION OF SOCIAL PREFERENCE WEIGHTS : IMPLICATIONS
FOR COST-EFFECTIVENESS

Cleemput I1, Kind P2, Kesteloot K1, 1Catholic University Leuven, Leuven, Belgium; 2University of York, York, United Kingdom

ISPOR Best Contributed Poster Presentation Award

BEST GENERAL POSTER PRESENTATIONS

POD10 IMPROVEMENT IN QUALITY OF LIFE IN GROWTH HORMONE (GH) REPLACED HYPOPITUITARY ADULTS WITH GH DEFICIENCY IS CORRELATED WITH PATIENT-REPORTED OUTCOMES: ANALYSIS OF THE KIMS DATABASE
Koltowska - Häggström M1, Mattsson A2, Svensson J3, Johannsson G3, Rosen T4, 1KIGS/KIMS Outcomes Research, Stockholm, Sweden; 2KIGS/KIMS Outcomes Research, Pharmacia AB, Stockholm, Sweden; 3Research Centre for Endocrinology and Metabolism, Sahlgrenska University Hospital, Göteborg, Sweden; 4Sahlgrenska University Hospital, Gothenborg, Sweden

PHP13 INFLUENCING PRESCRIBING IN ENGLISH PRIMARY CARE: FINDINGS FROM THE MANMED SURVEY
Mason A1, Drummond M1, Towse A2, Cooke J3, 1University of York, York, United Kingdom; 2Office of Health Economics, London, United Kingdom; 3South Manchester University Hospitals NHS Trust, Manchester, United Kingdom
PHP28 ECONOMIC STUDY OF MALNUTRITION IN ELDERLY PATIENTS LIVING IN THE COMMUNITY : USE OF PROPENSITY SCORE TO ANALYZE OBSERVATIONAL DATA
Schmitt C1, Aussage P1, Arnaud-Battandier F2, 1MDS Pharma Services, Sevres, France; 2Nestlé Clinical Nutrition, Noisiel, France

BEST NEW INVESTIGATOR POSTER PRESENTATIONS

PNP5 DIRECT COSTS OF BACK PAIN IN THE UNITED STATES: A NATIONAL ESTIMATE
Mychaskiw MA, Thomas III J, Purdue University, West Lafayette, IN, USA

PCN2 COST-EFFECTIVENESS OF NEW CERVICAL CANCER SCREENING TECHNOLOGIES.
A GERMAN HEALTH TECHNOLOGY ASSESSMENT AND DECISION-ANALYSIS.
Sroczynski G1, Siebert U1, Voigt K2, Gibis B3, Aidelsburger P4, Wasem J4, Hillemanns P2, Engel J2, Hölzel D2, Goldie S1, 1Harvard School of Public Health, Boston, MA, USA; 2University Munich, Munich, Germany; 3National Association of Statutory Health Insurance Physicians, Berlin, Germany; 4University of Greifswald, Greifswald, Germany

PGS16 EVALUATION OF THE USE OF PROTON PUMP INHIBITORS IN A PUBLIC HOSPITAL IN HONG KONG
Lee VW1, Yick PK2, Yung G1, Tam KY1, 1The Chinese University of Hong Kong, Shatin, Hong Kong; 2Pamela Youde Nethersole Eastern Hospital, Hong Kong

BEST STUDENT POSTER PRESENTATIONS

PWM9 ASSOCIATION BETWEEN PATERNAL EXPOSURE TO SOLVENTS AND FETAL MALFORMATIONS
de vries LE1, Logman JFS1, Hemels EH2, Khattak S3, Einarson T2, 1University of Toronto, Toronto, ON, Canada; 2University of Toronto, Toronto, ON, Canada; 3Biopharmatrials Inc, Whitby, ON, Canada

PWM8 ASSOCIATION BETWEEN PATERNAL EXPOSURE TO SOLVENTS AND SPONTANEOUS ABORTIONS
Logman JFS1, de Vries LE1, Hemels M1, Khattak S2, Einarson T1, 1University of Toronto, Toronto, ON, Canada; 2Biopharmatrials Inc, Whitby, ON, Canada

PIN21 HOSPITALISATION COSTS FOR YOUNG CHILDREN WITH RESPIRATORY
SYNCYTIAL VIRUS INFECTION

Vergouwe Y1, Polder JJ1, Rietveld E2, de Jonge EH1, Veeze HJ3, Moll HA2, Steyerberg EW1, 1Erasmus Medical Center, Rotterdam, Netherlands; 2Erasmus Medical Center-Sophia, Rotterdam, Netherlands; 3IJsselland Hospital, Capelle a/d IJssel, Netherlands

A special thanks goes to all the judges, the ISPOR Annual European Congress Awards Task Force Co-Chairs as well as the ISPOR Awards Committee Chair who volunteered their time and efforts in selecting the winners.

ISPOR AWARDS COMMITTEE CHAIR:
Newell McElwee PharmD, MSPH, Pfizer

ISPOR ANNUAL EUROPEAN CONGRESS AWARDS TASK FORCE CO-CHAIRS:
Jenifer Ehreth PhD - Medtronic Europe Sa (Poster)
Wolfgang Greiner PhD - University of Hannover (Podium)

ISPOR JUDGES:
Hiroshi Aino MS, Kobe University; Judith Baker PhD, CPA, Resource Group, Ltd; Jamie Barner RPh, PhD, University of Texas at Austin; Stephen Beard MS, RTI Health Solutions; Rami Ben-Joseph PhD, Pharmacia Corporation; Gilles Berdeaux MD, Laboratoires Alcon France; Annabel Boler BSc, Heron Evidence Development; Dale Christensen PhD, University of North Carolina; Peter Divinyi MD, Ministry of Health, Medical Devices Authority; Pennifer Erickson PhD, O.L.G.A.; Joelle Erkens PhD, PharmD, PHARMO Institute; DS Pete Fullerton PhD, University of Washington; Isabelle Girod MSC, Mapi Values; Andreas Guhl MD, BIOGEN.S.A.; Dr. Laszlo Gulacsi, Budapest University; Ali Haeri PhD, Pasteur Institute, Ministry of Health & Medical Education; Klaus Hieke, NEOS Health AG; Daniel Huse MA, Innovus Research Inc.; Lena Jacobson, Pfizer AB; Bas Janssen Msc, Academic Medical Centre; K. Ian Johnson, Interphase; Gwendoline Kiebert PhD, Pfizer Inc; Thomas Klose PhD, GlaxoSmithKline; Maria Koltowska MD, Pharmacia AB; Antoine Lafuma, CEMKA-EVAL; Xavier Lenne, CRESGE; Eva Lydick PhD, AstraZeneca Inc; Bradley Martin PharmD, PhD, University of Georgia; Susan Mathias MPH, Ovation Research Group; Josephine Mauskopf PhD, MEDTAP International; Colleen Metge PhD, University of Manitoba; Patrick Mollon MD, MBA, Pfizer Ltd; Helma Monteban, Pfizer bv; Brenda Motheral RPh, PhD, Express Scripts; C. Daniel Mullins PhD, University of Maryland; Marko A. Mychaskiw PhD, Purdue University; Christel Naujoks MSc, Novartis Pharma GmbH; Niels Neymark MSc, EORTC; Beth O’Leary, Quintiles; Jan Oostenbrink MSc, iMTA, Erasmus University Rotterdam; John E Paul PhD, RTI Health Solutions; Pedro Plans-Rubio MD, MHA, MBA, Dept Sanitat; Jonathan Plumb MS, AstraZeneca UK Ltd; Maarten Jacobus Postma PhD, Groningen Univ Institute for Drug Exploration; Karen Rascati RPh, PhD, University of Texas; Meir Raz MD, Maccabi Healthcare Services; Edit Remak, MEDTAP International; Mason W. Russell, MAPE BIOGEN, Inc.; Maureen Rutten-van Mölken PhD, iMTA, Erasmus University; Stephen Ryan MD, MA, University of Kentucky; Dr. Eugene Salole, Johnson & Johnson Medical; Elly A. Stolk MSc, Institute for Medical Technology Assessment; Marco Tangelder MD, PhD, Pharmacia; Betina Thordal Blak MSc, University of Maryland; Marianne van Genugten, National Institute of Public Health & the Environment; Henri Vanden Baviere MD, BIGE-IBES; Birgitta von Scheele MS, RTI-Health Solutions; Robert Welte MSc, MPH, University of Ulm; Kathleen A. Weis PhD, Pfizer, Inc; Richard Willke PhD, Pharmacia; Jerome Wilson PhD, Pfizer Pharmaceuticals; Rochelle Yalkowsky, University of Arizona

Jennifer Ehreth PhD and Newell McElwee PharmD, MSPH pictured below presenting the Scientific Awards

   
 

Poster Award winner: Mike Drummond

Contributed Poster Award winner:
M Koltowska-Häggström

 
   
 

Contributed Paper Award winner:
 Floris Logman

Contributed Paper Award winner: Laurens de Vries

 

  Issues Index | 2002 Issues Index